A new study shows that increasing your muscle strength and aerobic fitness could cut your chances of dying from cancer by up ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Media ReleaseMarking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer ...

Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

Cancer is treated with multiple modalities simultaneously, such as surgery, chemotherapy, and radiation therapy.

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

According to the Estonian Health Insurance Fund, lung cancer screening, which for the past three years, has been piloted in ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

By Mallika Marshall, MD Click here for updates on this story BOSTON, Massachusetts (WBZ) -- Patients with lung nodules often ...